Furthermore, our demonstration of reduced incidence of low–moderate grade but not high-grade prostate cancer among men with diabetes supports the possibility that low PSA levels, rather than lower tumour risk, may explain the observed reduced incidence of prostate cancer. This evidence concerns the gene KLK3 and prostate cancer.